The tax commissioner is challenging last month’s loss in a $948 million capital gains dispute with Malaysia’s YTL Power.
German pharmaceutical company Heidelberg Pharma has filed a lawsuit against Australian drug maker Telix alleging breach of a licence agreement for its kidney cancer diagnostic drug Zircaix.
Treasurer Jim Chalmers has blocked Cosette’s $672 million takeover of Mayne Pharma on national interest grounds after the US drug maker threatened to close a critical drug facility in Adelaide.
A judge has stayed a bid by the Illawarra Hawks and Melbourne Phoenix basketball clubs for preliminary discovery to determine whether to pursue claims against the National Basketball League.
Jewellery chain Lovisa has avoided an early mediation in an underpayments class action, after slamming it as an invitation to “pay money to make the case go away”.
The Australian intends to bring a truth defence in defamation claims by dismissed executives of commercial real estate broker Jones Lang LaSalle, a court has heard.
Macquarie Asset Management has made an offer to acquire Qube which values the infrastructure giant at $11.6 billion.
A construction project superintendent who revised down costs previously paid to the builder contracted on the Shenton Quarter development in Perth acted outside the terms of the contract, a court has found.
A court has shut down an investor’s $455,000 suit against defunct property development group Lion Property Group, finding its liquidators are better placed to untangle the claims.
A court has thrown out a bid by the developer of a Melbourne apartment block to challenge the scope of powers of an administrator appointed by the Victorian Civil and Administrative Tribunal to deal with significant defects.